NC3Rs Workshop: Applying exposure science to increase the utility of non-animal data in efficacy and safety testing Feb 15, 2017 20170215 Feb 16, 2017 Gibbs Building, 215 Euston Road, London NW1 2BE, UK The meeting will bring together academic and industry researchers across multiple disciplines to share their knowledge and experiences in applying exposure science to increase the utility of in vitro and in silico data for decision-making, efficacy and safety assessment.  The workshop will be attended by expert scientists from academia, government and regulatory agencies and the (agro)chemicals, consumer products, and pharmaceutical industries. The key objectives of the workshop are to: Increase awareness and build confidence in the application of exposure-driven approaches to support decision-making based on data from non-animal approaches across sectors; Build a community of scientists working in the area of exposure-driven safety assessment; Identify gaps and challenge areas that need to be addressed to advance the application of exposure science capability; Develop and publish guidance to facilitate the use and wider acceptance of exposure-driven non-animal approaches to inform and improve safety and efficacy decision-making. PMI Science also won a PETA award for our collaborative efforts towards Adverse Outcome Pathway (AOP) Wiki. To read more: https://www.technologynetworks.com/tn/news/philip-morris-international-and-british-american-tobacco-win-peta-award-for-3rs-work-281597 /content/dam/pmiscience/default-fallback-thumbnails/conference/pmi-scienist-working-in-laboratory-3840x2160.jpg

      NC3Rs Workshop: Applying exposure science to increase the utility of non-animal data in efficacy and safety testing

      Date
      Feb 15, 2017 - Feb 16, 2017
      Location
      Gibbs Building, 215 Euston Road, London NW1 2BE, UK
      The meeting will bring together academic and industry researchers across multiple disciplines to share their knowledge and experiences in applying exposure science to increase the utility of in vitro and in silico data for decision-making, efficacy and safety assessment.  The workshop will be attended by expert scientists from academia, government and regulatory agencies and the (agro)chemicals, consumer products, and pharmaceutical industries. The key objectives of the workshop are to: Increase awareness and build confidence in the application of exposure-driven approaches to support decision-making based on data from non-animal approaches across sectors; Build a community of scientists working in the area of exposure-driven safety assessment; Identify gaps and challenge areas that need to be addressed to advance the application of exposure science capability; Develop and publish guidance to facilitate the use and wider acceptance of exposure-driven non-animal approaches to inform and improve safety and efficacy decision-making. PMI Science also won a PETA award for our collaborative efforts towards Adverse Outcome Pathway (AOP) Wiki. To read more: https://www.technologynetworks.com/tn/news/philip-morris-international-and-british-american-tobacco-win-peta-award-for-3rs-work-281597

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.